By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Mirna Therapeutics, Inc. 

2150 Woodward Street
Suite 100
Austin  Texas  78744  U.S.A.
Phone: 512-901-0900 Fax: 512-681-5201


SEARCH JOBS








Company News
Marina Biotech, Inc. (MRNA) Announces That Licensee Mirna Therapeutics, Inc. Enrolls First Patient In Hematologic Malignancy Cohort Of On-Going Trial 6/12/2014 10:26:12 AM
Mirna Therapeutics, Inc.Announces First Patient Enrolled In Hematological Malignancy Cohort Of Its Phase 1 Clinical Trial 6/10/2014 10:00:16 AM
Mirna Therapeutics, Inc. Announces Interim Phase 1 Safety Data On Lead Product Candidate MRX34 at American Association for Cancer Research Annual Meeting 4/9/2014 6:29:12 AM
Mirna Therapeutics, Inc. Appoints Casi Deyoung As Chief Business Officer 3/19/2014 7:19:58 AM
Mirna Therapeutics, Inc. Announces Scientific Publication That Suggests Enhanced Potency Of Lead Therapeutic Microrna In Combination With FDA Approved Lung Cancer Dru 2/18/2014 9:54:40 AM
Mirna Therapeutics, Inc. Reports Expansion Of Intellectual Property Estate 1/14/2014 9:47:16 AM
Marina Biotech, Inc. And Mirna Therapeutics, Inc. Amend License Agreement For The Development Of microRNA-Based Therapeutics 1/2/2014 8:57:39 AM
Mirna Therapeutics, Inc. Expands Oncology Scientific Advisory Council 10/2/2013 6:46:53 AM
Mirna Therapeutics, Inc. Announces Important Expansion of microRNA Patent Portfolio 7/30/2013 10:05:49 AM
Mirna Therapeutics, Inc. and Horizon Discovery Ltd. Publication Elucidates Novel miR-34 Tumor Suppressor Pathway, Underscores miR-34 as Important Anticancer Approach 6/26/2013 9:45:57 AM
12345
//-->